Abstract
This invention relates to microporous/mesoporous or microporous/macroporous carbon and its use for the removal from blood of substances contrary to health. These include externally introduced toxins such as bacterially derived staphylococcus enterotoxins A, B, TSST-1 or autologous, biologically active molecules with harmful, systemic effects when their activity is excessive or unregulated. Examples include the removal of inappropriate amounts of pro- or anti-inflammatory molecules and toxic mediators of systemic inflammatory response syndrome related to sepsis, cardio-pulmonary by-pass surgery, ischaemic reperfusion injury; the removal of larger molecular weight and protein bound uremic and liver toxins related to chronic kidney and liver failure respectively, the removal of toxins relevant to biological and chemical warfare.
| Original language | English |
|---|---|
| Publication status | Published - 16 Jun 2011 |